• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于邻居的协同过滤并去除全局效应进行抗癌药物反应预测。

Anti-cancer Drug Response Prediction Using Neighbor-Based Collaborative Filtering with Global Effect Removal.

作者信息

Liu Hui, Zhao Yan, Zhang Lin, Chen Xing

机构信息

School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, China.

School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, China.

出版信息

Mol Ther Nucleic Acids. 2018 Dec 7;13:303-311. doi: 10.1016/j.omtn.2018.09.011. Epub 2018 Sep 22.

DOI:10.1016/j.omtn.2018.09.011
PMID:30321817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6197792/
Abstract

Patients of the same cancer may differ in their responses to a specific medical therapy. Identification of predictive molecular features for drug sensitivity holds the key in the era of precision medicine. Human cell lines have harbored most of the same genetic changes found in patients' tumors and thus are widely used in the research of drug response. In this work, we formulated drug-response prediction as a recommender system problem and then adopted a neighbor-based collaborative filtering with global effect removal (NCFGER) method to estimate anti-cancer drug responses of cell lines by integrating cell-line similarity networks and drug similarity networks based on the fact that similar cell lines and similar drugs exhibit similar responses. Specifically, we removed the global effect in the available responses and shrunk the similarity score for each cell line pair as well as each drug pair. We then used the K most similar neighbors (hybrid of cell-line-oriented and drug-oriented) in the available responses to predict the unknown ones. Through 10-fold cross-validation, this approach was shown to reach accurate and reproducible outcomes of drug sensitivity. We also discussed the biological outcomes based on the newly predicted response values.

摘要

患有相同癌症的患者对特定医学疗法的反应可能存在差异。在精准医学时代,识别药物敏感性的预测分子特征是关键所在。人类细胞系具有患者肿瘤中发现的大多数相同基因变化,因此被广泛用于药物反应研究。在这项工作中,我们将药物反应预测表述为一个推荐系统问题,然后采用一种基于邻居的去除全局效应的协同过滤(NCFGER)方法,通过整合细胞系相似性网络和药物相似性网络来估计细胞系的抗癌药物反应,这是基于相似的细胞系和相似的药物表现出相似反应这一事实。具体而言,我们去除了可用反应中的全局效应,并缩小了每个细胞系对以及每个药物对的相似性得分。然后,我们在可用反应中使用K个最相似的邻居(细胞系导向和药物导向的混合)来预测未知反应。通过10折交叉验证,该方法被证明能得出准确且可重复的药物敏感性结果。我们还基于新预测的反应值讨论了生物学结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/f243e19be6c4/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/4605c53adf84/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/aeac3ce3e2de/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/9703e1a28ec3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/b2ea06987d8d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/80bdae131ea4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/31f1c29c9584/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/6bb9011498ce/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/f243e19be6c4/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/4605c53adf84/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/aeac3ce3e2de/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/9703e1a28ec3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/b2ea06987d8d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/80bdae131ea4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/31f1c29c9584/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/6bb9011498ce/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4096/6197792/f243e19be6c4/gr7.jpg

相似文献

1
Anti-cancer Drug Response Prediction Using Neighbor-Based Collaborative Filtering with Global Effect Removal.使用基于邻居的协同过滤并去除全局效应进行抗癌药物反应预测。
Mol Ther Nucleic Acids. 2018 Dec 7;13:303-311. doi: 10.1016/j.omtn.2018.09.011. Epub 2018 Sep 22.
2
A Hybrid Interpolation Weighted Collaborative Filtering Method for Anti-cancer Drug Response Prediction.一种用于抗癌药物反应预测的混合插值加权协同过滤方法
Front Pharmacol. 2018 Sep 12;9:1017. doi: 10.3389/fphar.2018.01017. eCollection 2018.
3
Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.使用具有相似性正则化的矩阵分解改进细胞系中抗癌药物反应预测。
BMC Cancer. 2017 Aug 2;17(1):513. doi: 10.1186/s12885-017-3500-5.
4
A comparative study: classification vs. user-based collaborative filtering for clinical prediction.一项比较研究:用于临床预测的分类法与基于用户的协同过滤法
BMC Med Res Methodol. 2016 Dec 8;16(1):172. doi: 10.1186/s12874-016-0261-9.
5
DSPLMF: A Method for Cancer Drug Sensitivity Prediction Using a Novel Regularization Approach in Logistic Matrix Factorization.DSPLMF:一种在逻辑矩阵分解中使用新型正则化方法进行癌症药物敏感性预测的方法。
Front Genet. 2020 Feb 27;11:75. doi: 10.3389/fgene.2020.00075. eCollection 2020.
6
Drug Response Prediction by Globally Capturing Drug and Cell Line Information in a Heterogeneous Network.通过在异构网络中全局捕获药物和细胞系信息来预测药物反应。
J Mol Biol. 2018 Sep 14;430(18 Pt A):2993-3004. doi: 10.1016/j.jmb.2018.06.041. Epub 2018 Jun 30.
7
Enhancing the scalability of distance-based link prediction algorithms in recommender systems through similarity selection.通过相似性选择增强推荐系统中基于距离的链接预测算法的可扩展性。
PLoS One. 2022 Jul 28;17(7):e0271891. doi: 10.1371/journal.pone.0271891. eCollection 2022.
8
Drug Response Prediction as a Link Prediction Problem.药物反应预测作为链接预测问题。
Sci Rep. 2017 Jan 9;7:40321. doi: 10.1038/srep40321.
9
Strategies of similarity propagation in web service recommender systems.在 Web 服务推荐系统中进行相似性传播的策略。
Math Biosci Eng. 2020 Dec 11;18(1):530-550. doi: 10.3934/mbe.2021029.
10
A novel approach for drug response prediction in cancer cell lines via network representation learning.通过网络表示学习预测癌症细胞系中的药物反应的新方法。
Bioinformatics. 2019 May 1;35(9):1527-1535. doi: 10.1093/bioinformatics/bty848.

引用本文的文献

1
Multiomics-Driven Drug-Cell Interaction Network for Chemotherapy Sensitivity Prediction in Metabolically Defined Triple-Negative Breast Cancer Subtypes.用于代谢定义的三阴性乳腺癌亚型化疗敏感性预测的多组学驱动药物-细胞相互作用网络
J Cell Mol Med. 2025 Jun;29(11):e70572. doi: 10.1111/jcmm.70572.
2
Drug molecular representations for drug response predictions: a comprehensive investigation via machine learning methods.用于药物反应预测的药物分子表示:通过机器学习方法进行的全面研究。
Sci Rep. 2025 Jan 2;15(1):20. doi: 10.1038/s41598-024-84711-7.
3
BANDRP: a bilinear attention network for anti-cancer drug response prediction based on fingerprint and multi-omics.

本文引用的文献

1
Predicting Cancer Drug Response using a Recommender System.利用推荐系统预测癌症药物反应。
Bioinformatics. 2018 Nov 15;34(22):3907-3914. doi: 10.1093/bioinformatics/bty452.
2
A novel heterogeneous network-based method for drug response prediction in cancer cell lines.一种基于新型异质网络的癌症细胞系药物反应预测方法。
Sci Rep. 2018 Feb 20;8(1):3355. doi: 10.1038/s41598-018-21622-4.
3
Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells.
BANDRP:基于指纹和多组学的抗癌药物反应预测的双线性注意力网络。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae493.
4
A method combining LDA and neural networks for antitumor drug efficacy prediction.一种结合LDA和神经网络的抗肿瘤药物疗效预测方法。
Digit Health. 2024 Sep 9;10:20552076241280103. doi: 10.1177/20552076241280103. eCollection 2024 Jan-Dec.
5
Trust me if you can: a survey on reliability and interpretability of machine learning approaches for drug sensitivity prediction in cancer.相信我:一项关于机器学习方法在癌症药物敏感性预测中的可靠性和可解释性的调查。
Brief Bioinform. 2024 Jul 25;25(5). doi: 10.1093/bib/bbae379.
6
A comprehensive benchmarking of machine learning algorithms and dimensionality reduction methods for drug sensitivity prediction.机器学习算法和降维方法在药物敏感性预测中的全面基准测试。
Brief Bioinform. 2024 May 23;25(4). doi: 10.1093/bib/bbae242.
7
Cancer drug response prediction with surrogate modeling-based graph neural architecture search.基于替代模型的图神经网络架构搜索的癌症药物反应预测。
Bioinformatics. 2023 Aug 1;39(8). doi: 10.1093/bioinformatics/btad478.
8
Deep learning methods for drug response prediction in cancer: Predominant and emerging trends.用于癌症药物反应预测的深度学习方法:主流与新趋势
Front Med (Lausanne). 2023 Feb 15;10:1086097. doi: 10.3389/fmed.2023.1086097. eCollection 2023.
9
DEML: Drug Synergy and Interaction Prediction Using Ensemble-Based Multi-Task Learning.DEML:基于集成的多任务学习的药物协同和相互作用预测。
Molecules. 2023 Jan 14;28(2):844. doi: 10.3390/molecules28020844.
10
Drug response prediction using graph representation learning and Laplacian feature selection.基于图表示学习和拉普拉斯特征选择的药物反应预测。
BMC Bioinformatics. 2022 Dec 9;23(Suppl 8):532. doi: 10.1186/s12859-022-05080-4.
PP2A癌性抑制剂(CIP2A)的激活通过在ErbB2阳性乳腺癌细胞中诱导CIP2A-Akt反馈环导致拉帕替尼耐药。
Oncotarget. 2017 Jul 19;8(35):58847-58864. doi: 10.18632/oncotarget.19375. eCollection 2017 Aug 29.
4
The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis.拉帕替尼和卡培他滨治疗HER-2阳性脑转移乳腺癌的疗效:一项系统评价与汇总分析
Eur J Cancer. 2017 Oct;84:141-148. doi: 10.1016/j.ejca.2017.07.024. Epub 2017 Aug 12.
5
Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.使用具有相似性正则化的矩阵分解改进细胞系中抗癌药物反应预测。
BMC Cancer. 2017 Aug 2;17(1):513. doi: 10.1186/s12885-017-3500-5.
6
Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models.在拉帕替尼不敏感的乳腺癌模型中,使用基于高斯过程的方法鉴定潜在的新治疗反应标志物和治疗靶点。
PLoS One. 2017 May 8;12(5):e0177058. doi: 10.1371/journal.pone.0177058. eCollection 2017.
7
Drug Response Prediction as a Link Prediction Problem.药物反应预测作为链接预测问题。
Sci Rep. 2017 Jan 9;7:40321. doi: 10.1038/srep40321.
8
Integrating Domain Specific Knowledge and Network Analysis to Predict Drug Sensitivity of Cancer Cell Lines.整合特定领域知识与网络分析以预测癌细胞系的药物敏感性。
PLoS One. 2016 Sep 8;11(9):e0162173. doi: 10.1371/journal.pone.0162173. eCollection 2016.
9
Evaluating the molecule-based prediction of clinical drug responses in cancer.评估基于分子的癌症临床药物反应预测。
Bioinformatics. 2016 Oct 1;32(19):2891-5. doi: 10.1093/bioinformatics/btw344. Epub 2016 Jun 9.
10
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives.PI3K/Akt/mTOR 和 Ras/Raf/MEK/ERK 信号通路抑制剂作为抗癌药物:结构和药理学视角。
Eur J Med Chem. 2016 Feb 15;109:314-41. doi: 10.1016/j.ejmech.2016.01.012. Epub 2016 Jan 12.